Product

J Antiinfectives For Systemic Use

Image Product Name API Name Last Drug Patent Expires Details Year of start producing
//imrorwxhnlprli5q.ldycdn.com/cloud/jpBpqKkrllSRiknpokjlio/2375019-60-60.gif CAS No. 2375019-85-3, 2-Pyridinemethanamine, 3-bromo-α-[(3,5-difluorophenyl)methyl]-6-[3-methyl-3-(methylsulfonyl)-1-butyn-1-yl]-, (αS)- Lenacapavir 8/16/2038 (Lenacapavir) View detail »
//imrorwxhnlprli5q.ldycdn.com/cloud/jpBpqKkrllSRikiijlnnin/1620056-60-60.gif Cas No. 1620056-47-4, Carbamic acid, N-[(1S)-1-(3,6-dibromo-2-pyridinyl)-2-(3,5-difluorophenyl)ethyl]-, 1,1-dimethylethyl ester Lenacapavir 8/16/2038 (Lenacapavir) View detail »
//imrorwxhnlprli5q.ldycdn.com/cloud/jlBpqKkrllSRikiijlroin/2189684-60-60.gif Cas No. 2189684-53-3, 1H-Indazol-3-amine, 4-chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2,2,2-trifluoroethyl)- Lenacapavir 8/16/2038 (Lenacapavir) View detail »
//imrorwxhnlprli5q.ldycdn.com/cloud/jmBpqKkrllSRikiijlonin/1620056-60-60.gif Cas No. 1620056-83-8, 1H-Cyclopropa[3,4]cyclopenta[1,2-c]pyrazole-1-acetic acid, 5,5-difluoro-3b,4,4a,5-tetrahydro-3-(trifluoromethyl)-, (3bS,4aR)- Lenacapavir 8/16/2038 (Lenacapavir) View detail »
//imrorwxhnlprli5q.ldycdn.com/cloud/jjBpqKkrllSRikiijlmnio/2189684-60-60.gif Cas No. 2189684-54-4, Carbamic acid,N-[(1S)-1-[3-bromo-6-[3-methyl-3-(methylsulfonyl)-1-butyn-1-yl]-2-pyridinyl]-2-(3,5-difluorophenyl)ethyl]-,1,1-dimethylethyl ester Lenacapavir 8/16/2038 (Lenacapavir) View detail »
//imrorwxhnlprli5q.ldycdn.com/cloud/lpBpqKkrllSRnkpnmmlqip/2109226-60-60.gif Cas No. 2109226-54-0, 3-Methyl-3-(methylsulfonyl)but-1-yne Lenacapavir 8/16/2038 (Lenacapavir) View detail »
//imrorwxhnlprli5q.ldycdn.com/cloud/jrBpqKkrllSRikiijlqnio/1809323-60-60.gif Cas No. 1809323-20-3, 2-(5-bromopyridin-2-y)-2,2-difluoro-1-morpholinoethanone Oteseconazole 3/17/2036 (Oteseconazole) View detail »
//imrorwxhnlprli5q.ldycdn.com/cloud/lkBpqKkrllSRqjqpnokqip/oritavancin-60-60.png CAS No.171099-57-3, Oritavancin Oritavancin 7/16/2035 (Oritavancin) View detail »
//imrorwxhnlprli5q.ldycdn.com/cloud/ljBpqKkrllSRqjqprmriiq/118395-60-60.png CAS No.118395-73-6, Chloroeremomycin Oritavancin 7/16/2035 (Oritavancin) View detail »
//imrorwxhnlprli5q.ldycdn.com/cloud/jnBpqKkrllSRikiijllkin/861347-60-60.gif Cas No. 861347-86-6, 3-Chloro-5-iodophenol Doravirine 10/7/2031 (Doravirine) View detail »
//imrorwxhnlprli5q.ldycdn.com/cloud/jqBpqKkrllSRikjolmmqiq/252742-60-60.gif CAS No. 252742-72-6, 3-(chloromethyl)-1,4-dihydro-1,2,4-triazol-5-one Doravirine; Aprepitant; Fosaprepitant 10/7/2031 (Doravirine); 9/18/2035 (Aprepitant); 1/11/2039 (Fosaprepitant) View detail »
//imrorwxhnlprli5q.ldycdn.com/cloud/jjBpqKkrllSRikiijlrlin/1155846-60-60.gif Cas No. 1155846-86-8, Benzonitrile, 3-chloro-5-[[1,2-dihydro-2-oxo-4-(trifluoromethyl)-3-pyridinyl]oxy]- Doravirine 10/7/2031 (Doravirine) View detail »
//imrorwxhnlprli5q.ldycdn.com/cloud/lnBpqKkrllSRkkkonrpmiq/Dalbavancin-b0-60-60.gif CAS No.110882-84-3, antibiotic A-40926 B0 Dalbavancin Hydrochloride 5/2/2028 (Dalbavancin Hydrochloride) View detail »
//imrorwxhnlprli5q.ldycdn.com/cloud/lrBpqKkrllSRqjppopijip/imgsrv-60-60.png Dalbavancin Hydrochloride Dalbavancin Hydrochloride 5/2/2028 (Dalbavancin Hydrochloride) View detail »